MATCH Arm EAY131-V

**Semantic type:** Intellectual Product

**Definition:** The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with sunitinib in patients with tumors that have KIT gene mutations, excluding gastrointestinal stromal tumors (GIST), renal cell cancers and pancreatic neuroendocrine tumors.

**Synonyms:** - EAY131-V - V